HPA015037

antibody from Atlas Antibodies

Targeting: ARID5B FLJ21150, MRF2

Immunocytochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

HPA015037

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#HPA015037, RRID:AB_1845015

Product name

Anti-ARID5B

Antibody type

Polyclonal

Description

Polyclonal Antibody against Human ARID5B, Gene description: AT rich interactive domain 5B (MRF1-like), Alternative Gene Names: FLJ21150, MRF2, Validated applications: ICC, Uniprot ID: Q14865, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

100 µl

Concentration

0.1 mg/ml

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Handling

The antibody solution should be gently mixed before use.

References

Submitted references

Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification.

Kavousi M, Bos MM, Barnes HJ, Lino Cardenas CL, Wong D, Lu H, Hodonsky CJ, Landsmeer LPL, Turner AW, Kho M, Hasbani NR, de Vries PS, Bowden DW, Chopade S, Deelen J, Benavente ED, Guo X, Hofer E, Hwang SJ, Lutz SM, Lyytikäinen LP, Slenders L, Smith AV, Stanislawski MA, van Setten J, Wong Q, Yanek LR, Becker DM, Beekman M, Budoff MJ, Feitosa MF, Finan C, Hilliard AT, Kardia SLR, Kovacic JC, Kral BG, Langefeld CD, Launer LJ, Malik S, Hoesein FAAM, Mokry M, Schmidt R, Smith JA, Taylor KD, Terry JG, van der Grond J, van Meurs J, Vliegenthart R, Xu J, Young KA, Zilhão NR, Zweiker R, Assimes TL, Becker LC, Bos D, Carr JJ, Cupples LA, de Kleijn DPV, de Winther M, den Ruijter HM, Fornage M, Freedman BI, Gudnason V, Hingorani AD, Hokanson JE, Ikram MA, Išgum I, Jacobs DR Jr, Kähönen M, Lange LA, Lehtimäki T, Pasterkamp G, Raitakari OT, Schmidt H, Slagboom PE, Uitterlinden AG, Vernooij MW, Bis JC, Franceschini N, Psaty BM, Post WS, Rotter JI, Björkegren JLM, O'Donnell CJ, Bielak LF, Peyser PA, Malhotra R, van der Laan SW, Miller CL
Nature genetics 2023 Oct;55(10):1651-1664

---

Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors

Yamato A, Nagano H, Gao Y, Matsuda T, Hashimoto N, Nakayama A, Yamagata K, Yokoyama M, Gong Y, Shi X, Zhahara S, Kono T, Taki Y, Furuki N, Nishimura M, Horiguchi K, Iwadate Y, Fukuyo M, Rahmutulla B, Kaneda A, Hasegawa Y, Kawashima Y, Ohara O, Ishikawa T, Kawakami E, Nakamura Y, Inoshita N, Yamada S, Fukuhara N, Nishioka H, Tanaka T
Communications Biology 2022;5(1)

---

ARID5B Influences Antimetabolite Drug Sensitivity and Prognosis of Acute Lymphoblastic Leukemia

Xu H, Zhao X, Bhojwani D, E S, Goodings C, Zhang H, Seibel N, Yang W, Li C, Carroll W, Evans W, Yang J
Clinical Cancer Research 2020;26(1):256-264

---

ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis

Leong W, Tan S, Ngoc P, Amanda S, Yam A, Liau W, Gong Z, Lawton L, Tenen D, Sanda T
Genes & Development 2017;31(23-24):2343-2360

---

Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge

Tan M, Singh B, Kinne H, Milligan R, Washburn L, Olsen M, Lucci A
PLOS ONE 2016;11(7):e0159072

Immunocytochemistry

Supportive validation

Submitted by

Atlas Antibodies (provider)

Main image

Experimental details

Immunofluorescent staining of human cell line BJ shows localization to nucleoplasm & endoplasmic reticulum.

Sample type

Human